Trademarkia Logo

Canada

C$
NOGRADERM
REGISTERED

on 24 Nov 2023

Last Applicant/ Owned by

NOGRA PHARMA LIMITED

33 Sir John Rogerson's QuayDublin 2

IE

Serial Number

2071566 filed on 28th Sept 2020

Registration Number

TMA1210549 registered on 24th Nov 2023

Registration expiry Date

28th Sept 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

NOGRADERM

Trademark usage description

pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; dermatological preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; antibiotic dermatological products, namely, creams and gels for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; dermatological pharmaceutical substances for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; dermatological pharmaceutical products, namely, creams and gels for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; gels for dermatological use for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; creams for dermatological use for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases


Classification kind code

11

Class [042]
Research and development for the pharmaceutical industry; pharmaceutical research and development; pharmaceutical products development; consultancy relating to pharmaceutical research and development.


Classification kind code

11

Mark Details


Serial Number

2071566

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 11th Apr 2022
Search Recorded
Submitted for opposition 20
on 11th Apr 2022
Examiner's First Report
Submitted for opposition 223
on 11th Apr 2022
Total Provisional Refusal
Submitted for opposition 256
on 18th Oct 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 4th Mar 2021
Agent Changed
Submitted for opposition 257
on 17th Dec 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 16th Dec 2020
Formalized
Submitted for opposition 1
on 16th Dec 2020
Created
Submitted for opposition 228
on 28th Sept 2020
International Registration
Submitted for opposition 30
on 28th Sept 2020
Filed